Biotech

All Articles

Lykos will certainly talk to FDA to rethink its own decision following being rejected of MDMA therapy for trauma

.Observing a bad showing for Lykos Therapeutics' MDMA applicant for post-traumatic stress disorder a...

AN 2 one-halfs roll call, stops phase 3 trial after information disappoint

.AN2 Rehabs is actually rethinking its own organization in action to lackluster midphase records, vo...

Merck pays out $700M for bispecific, spying autoimmune opening and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying for $700 thousand in advance to challenge Amgen in a blood cancer market. ...

Gilead pays J&ampJ $320M to leave licensing deal for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its own liver health condition medication ...

' All palms on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can find the companies setting up outdoors tents at basecamp be...

Entero laying off workers, abandoning workplace and stopping R&ampD

.Bed mattress Liquidators has switched Entero Therapies white as a sheet. The financial institution ...

Exelixis loses ADC after deciding it's no match for Tivdak

.Exelixis is actually surrendering on its cells aspect (TF)- targeting antibody-drug conjugate after...

Relay dislikes SHP2 inhibitor after Genentech leaves

.Three weeks after Roche's Genentech system bowed out an SHP2 inhibitor pact, Relay Therapy has conf...

Stoke's Dravet syndrome med launched of predisposed scientific hold

.Stoke Therapeutics' Dravet syndrome medicine has been actually freed from a partial grip, clearing ...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Tough Biotech Colleague Editor Gabrielle Masson provided the 2024 course of Ferocious 15 winners on...